• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用转录组分析研究甲状腺乳头状癌的发病机制。

Investigating the mechanisms of papillary thyroid carcinoma using transcriptome analysis.

机构信息

Otolaryngology Head and Neck Surgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, P.R. China.

Radiology Department, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, P.R. China.

出版信息

Mol Med Rep. 2017 Nov;16(5):5954-5964. doi: 10.3892/mmr.2017.7346. Epub 2017 Aug 24.

DOI:10.3892/mmr.2017.7346
PMID:28849102
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5865774/
Abstract

As the predominant thyroid cancer, papillary thyroid cancer (PTC) accounts for 75‑85% of thyroid cancer cases. This research aimed to investigate transcriptomic changes and key genes in PTC. Using RNA‑sequencing technology, the transcriptional profiles of 5 thyroid tumor tissues and 5 adjacent normal tissues were obtained. The single nucleotide polymorphisms (SNPs) were identified by SAMtools software and then annotated by ANNOVAR software. After differentially expressed genes (DEGs) were selected by edgR software, they were further investigated by enrichment analysis, protein domain analysis, and protein‑protein interaction (PPI) network analysis. Additionally, the potential gene fusion events were predicted using FusionMap software. A total of 70,172 SNPs and 2,686 DEGs in the tumor tissues, as well as 83,869 SNPs in the normal tissues were identified. In the PPI network, fibronectin 1 (FN1; degree=31) and transforming growth factor β receptor 1 (TGFβR1; degree=22) had higher degrees. A total of 7 PPI pairs containing the non‑synonymous risk SNP loci in the interaction domains were identified. Particularly, the interaction domains involved in the interactions of FN1 and 5 other proteins (such as FN1‑tenascin C, TNC) had non‑synonymous risk SNP loci. Furthermore, 11 and 4 gene fusion events were identified in all of the tumor tissues and normal tissues, respectively. Additionally, the NK2 homeobox 1‑surfactant associated 3 (NKX2‑1‑SFTA3) gene fusion was identified in both tumor and normal tissues. These results indicated that TGFβR1 and the NKX2‑1‑SFTA3 gene fusion may be involved in PTC. Furthermore, FN1 and TNC containing the non‑synonymous risk SNP loci might serve a role in PTC by interacting with each other.

摘要

作为最常见的甲状腺癌,甲状腺乳头状癌(papillary thyroid cancer,PTC)占甲状腺癌病例的 75%-85%。本研究旨在探讨 PTC 中的转录组变化和关键基因。采用 RNA 测序技术,获得了 5 例甲状腺肿瘤组织和 5 例相邻正常组织的转录谱。利用 SAMtools 软件识别单核苷酸多态性(single nucleotide polymorphisms,SNP),然后利用 ANNOVAR 软件进行注释。通过 edgR 软件选择差异表达基因(differentially expressed genes,DEGs)后,进一步进行富集分析、蛋白结构域分析和蛋白-蛋白相互作用(protein-protein interaction,PPI)网络分析。此外,利用 FusionMap 软件预测潜在的基因融合事件。在肿瘤组织中鉴定出 70172 个 SNP 和 2686 个 DEGs,在正常组织中鉴定出 83869 个 SNP。在 PPI 网络中,纤维连接蛋白 1(fibronectin 1,FN1;degree=31)和转化生长因子β受体 1(transforming growth factor β receptor 1,TGFβR1;degree=22)具有较高的度。鉴定出 7 个包含相互作用域中非同义风险 SNP 位点的 PPI 对。特别是 FN1 与其他 5 种蛋白(如 FN1-腱糖蛋白 C、TNC)相互作用的相互作用域中存在非同义风险 SNP 位点。此外,在所有肿瘤组织和正常组织中分别鉴定出 11 个和 4 个基因融合事件。此外,在肿瘤和正常组织中均鉴定出 NK2 同源盒 1-表面活性剂相关蛋白 3(NK2 homeobox 1-surfactant associated 3,NKX2-1-SFTA3)基因融合。这些结果表明,TGFβR1 和 NKX2-1-SFTA3 基因融合可能参与 PTC。此外,含有非同义风险 SNP 位点的 FN1 和 TNC 可能通过相互作用在 PTC 中发挥作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d4b/5865774/b301dfbf88fd/mmr-16-05-5954-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d4b/5865774/4744656730c5/mmr-16-05-5954-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d4b/5865774/f619e991e542/mmr-16-05-5954-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d4b/5865774/312b84eec94f/mmr-16-05-5954-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d4b/5865774/1e86b0785bad/mmr-16-05-5954-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d4b/5865774/b301dfbf88fd/mmr-16-05-5954-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d4b/5865774/4744656730c5/mmr-16-05-5954-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d4b/5865774/f619e991e542/mmr-16-05-5954-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d4b/5865774/312b84eec94f/mmr-16-05-5954-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d4b/5865774/1e86b0785bad/mmr-16-05-5954-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d4b/5865774/b301dfbf88fd/mmr-16-05-5954-g04.jpg

相似文献

1
Investigating the mechanisms of papillary thyroid carcinoma using transcriptome analysis.利用转录组分析研究甲状腺乳头状癌的发病机制。
Mol Med Rep. 2017 Nov;16(5):5954-5964. doi: 10.3892/mmr.2017.7346. Epub 2017 Aug 24.
2
The Landscape of Circular RNA Expression Profiles in Papillary Thyroid Carcinoma Based on RNA Sequencing.基于RNA测序的甲状腺乳头状癌中环状RNA表达谱特征
Cell Physiol Biochem. 2018;47(3):1122-1132. doi: 10.1159/000490188. Epub 2018 May 25.
3
Solute carrier family 35 member F2 is indispensable for papillary thyroid carcinoma progression through activation of transforming growth factor-β type I receptor/apoptosis signal-regulating kinase 1/mitogen-activated protein kinase signaling axis.溶质载体家族35成员F2通过激活转化生长因子-β I型受体/凋亡信号调节激酶1/丝裂原活化蛋白激酶信号轴,对甲状腺乳头状癌的进展至关重要。
Cancer Sci. 2018 Mar;109(3):642-655. doi: 10.1111/cas.13478. Epub 2018 Feb 1.
4
Network-based meta-analysis in the identification of biomarkers for papillary thyroid cancer.基于网络的荟萃分析在甲状腺乳头状癌生物标志物识别中的应用。
Gene. 2018 Jun 30;661:160-168. doi: 10.1016/j.gene.2018.03.096. Epub 2018 Apr 3.
5
New global analysis of the microRNA transcriptome of primary tumors and lymph node metastases of papillary thyroid cancer.甲状腺乳头状癌原发肿瘤和淋巴结转移灶的微小RNA转录组的新全球分析。
BMC Genomics. 2015 Oct 21;16:828. doi: 10.1186/s12864-015-2082-3.
6
Competing endogenous RNA regulatory network in papillary thyroid carcinoma.甲状腺乳头状癌中的竞争内源性 RNA 调控网络。
Mol Med Rep. 2018 Jul;18(1):695-704. doi: 10.3892/mmr.2018.9009. Epub 2018 May 11.
7
Identification of potential biomarkers and drugs for papillary thyroid cancer based on gene expression profile analysis.基于基因表达谱分析鉴定甲状腺乳头状癌的潜在生物标志物和药物。
Mol Med Rep. 2016 Dec;14(6):5041-5048. doi: 10.3892/mmr.2016.5855. Epub 2016 Oct 19.
8
Identification of Specific Long Non-Coding RNA Expression: Profile and Analysis of Association with Clinicopathologic Characteristics and BRAF Mutation in Papillary Thyroid Cancer.乳头状甲状腺癌中特异性长链非编码RNA表达的鉴定:表达谱及与临床病理特征和BRAF突变的相关性分析
Thyroid. 2016 Dec;26(12):1719-1732. doi: 10.1089/thy.2016.0024. Epub 2016 Oct 31.
9
Gene expression profile analyze the molecular mechanism of CXCR7 regulating papillary thyroid carcinoma growth and metastasis.基因表达谱分析CXCR7调控甲状腺乳头状癌生长和转移的分子机制。
J Exp Clin Cancer Res. 2015 Feb 12;34(1):16. doi: 10.1186/s13046-015-0132-y.
10
RNA sequencing identifies crucial genes in papillary thyroid carcinoma (PTC) progression.RNA测序确定了甲状腺乳头状癌(PTC)进展中的关键基因。
Exp Mol Pathol. 2016 Feb;100(1):151-9. doi: 10.1016/j.yexmp.2015.12.011. Epub 2015 Dec 18.

引用本文的文献

1
The role of PI3K signaling pathway and its associated genes in papillary thyroid cancer.PI3K 信号通路及其相关基因在甲状腺乳头状癌中的作用。
J Egypt Natl Canc Inst. 2021 May 17;33(1):11. doi: 10.1186/s43046-021-00068-2.
2
Eva-1 homolog A promotes papillary thyroid cancer progression and epithelial-mesenchymal transition via the Hippo signalling pathway.Eva-1 同源物 A 通过 Hippo 信号通路促进甲状腺乳头状癌的进展和上皮-间充质转化。
J Cell Mol Med. 2020 Nov;24(22):13070-13080. doi: 10.1111/jcmm.15909. Epub 2020 Sep 23.
3
High expression of NUCB2 promotes papillary thyroid cancer cells proliferation and invasion.

本文引用的文献

1
The Pfam protein families database: towards a more sustainable future.Pfam蛋白质家族数据库:迈向更可持续的未来。
Nucleic Acids Res. 2016 Jan 4;44(D1):D279-85. doi: 10.1093/nar/gkv1344. Epub 2015 Dec 15.
2
Genomic variant annotation and prioritization with ANNOVAR and wANNOVAR.使用ANNOVAR和wANNOVAR进行基因组变异注释和优先级排序。
Nat Protoc. 2015 Oct;10(10):1556-66. doi: 10.1038/nprot.2015.105. Epub 2015 Sep 17.
3
BigBWA: approaching the Burrows-Wheeler aligner to Big Data technologies.BigBWA:使Burrows-Wheeler比对器向大数据技术靠拢
NUCB2的高表达促进甲状腺乳头状癌细胞的增殖和侵袭。
Onco Targets Ther. 2019 Feb 18;12:1309-1318. doi: 10.2147/OTT.S184560. eCollection 2019.
Bioinformatics. 2015 Dec 15;31(24):4003-5. doi: 10.1093/bioinformatics/btv506. Epub 2015 Aug 30.
4
FoxP3 in papillary thyroid carcinoma induces NIS repression through activation of the TGF-β1/Smad signaling pathway.甲状腺乳头状癌中的FoxP3通过激活TGF-β1/Smad信号通路诱导钠碘同向转运体(NIS)抑制。
Tumour Biol. 2016 Jan;37(1):989-98. doi: 10.1007/s13277-015-3848-6. Epub 2015 Aug 12.
5
New somatic mutations and WNK1-B4GALNT3 gene fusion in papillary thyroid carcinoma.甲状腺乳头状癌中的新体细胞突变及WNK1-B4GALNT3基因融合
Oncotarget. 2015 May 10;6(13):11242-51. doi: 10.18632/oncotarget.3593.
6
J-Circos: an interactive Circos plotter.J-Circos:一个交互式 Circos 绘图工具。
Bioinformatics. 2015 May 1;31(9):1463-5. doi: 10.1093/bioinformatics/btu842. Epub 2014 Dec 24.
7
Association between BRAF V600E mutation and recurrence of papillary thyroid cancer.BRAF V600E突变与甲状腺乳头状癌复发之间的关联。
J Clin Oncol. 2015 Jan 1;33(1):42-50. doi: 10.1200/JCO.2014.56.8253. Epub 2014 Oct 20.
8
Thyroid cancer mortality and incidence: a global overview.甲状腺癌的死亡率和发病率:全球概述。
Int J Cancer. 2015 May 1;136(9):2187-95. doi: 10.1002/ijc.29251. Epub 2014 Oct 13.
9
BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence.BRAF V600E 和 TERT 启动子突变协同鉴定出最具侵袭性且复发率最高的甲状腺乳头状癌。
J Clin Oncol. 2014 Sep 1;32(25):2718-26. doi: 10.1200/JCO.2014.55.5094. Epub 2014 Jul 14.
10
RNA sequencing: from tag-based profiling to resolving complete transcript structure.RNA 测序:从基于标签的分析到解析完整的转录结构。
Cell Mol Life Sci. 2014 Sep;71(18):3537-51. doi: 10.1007/s00018-014-1637-9. Epub 2014 May 15.